Biblio
Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease. Stem Cell Res. 2015;15(3):584-594.
Donor immunization against human leukocyte class II antigens is a risk factor for graft-versus-host disease. Biol Blood Marrow Transplant. 2015.
IN VITRO CHARACTERIZATION OF PATCHES OF HUMAN MESENCHYMAL STROMAL CELLS. Tissue Eng Part A. 2014.
.